| Completed | Kubota Glass Parameter Refinement Study Myopia, Myopia, Progressive, Vision Disorders | N/A | 2023-11-01 |
| Recruiting | Electronic Spectacles Versus Low Dose Atropine in Young Myopes Myopia | N/A | 2023-10-01 |
| Unknown | Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device Myopia | N/A | 2022-06-23 |
| Completed | Evaluation of the Retinal Health Monitoring System Thickness Module Macular Edema, Macular Degeneration | — | 2020-11-11 |
| Completed | Projected Peripheral Defocus Using a Wearable Device Myopia | N/A | 2020-06-29 |
| Completed | Effects of Projected Peripheral Defocus on Ocular Biometrics Myopia | N/A | 2020-04-11 |
| Withdrawn | Study Evaluating Retinal Health Monitoring System Thickness Module Macular Edema, Macular Degeneration | — | 2020-04-01 |
| Completed | Study Evaluating Retinal Health Monitoring System Visual Acuity Module. Age Related Macular Degeneration | — | 2019-11-20 |
| Completed | Safety and Efficacy of Emixustat in Stargardt Disease Stargardt Disease | Phase 3 | 2019-01-07 |
| Completed | Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disea Stargardt Disease, Macular Atrophy | Phase 2 | 2017-01-01 |
| Completed | Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy Proliferative Diabetic Retinopathy | Phase 2 | 2016-05-01 |
| Completed | Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Geographic Atrophy, Age-Related Macular Degeneration | Phase 1 | 2014-04-01 |
| Completed | Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride Geographic Atrophy | Phase 2 / Phase 3 | 2013-02-01 |
| Completed | Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome Dry Eye Syndrome | Phase 3 | 2012-06-01 |
| Completed | Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hyp Primary Open-angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | 2011-09-01 |
| Completed | Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Keratoconjunctivitis Sicca, Dry Eye | Phase 2 | 2010-02-01 |
| Completed | Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye Dry Eye Syndromes, Keratoconjunctivitis Sicca | Phase 2 | 2009-12-01 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geograph Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | 2009-10-01 |
| Completed | Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects Healthy | Phase 1 | 2009-07-01 |
| Completed | Safety and Tolerability of ACU-4429 Healthy | Phase 1 | 2008-05-01 |